Due to health problems, psychological challenges, and socioeconomic circumstances that leave consequences for health, citizens in Bosnia and Herzegovina BiH increasingly decide to consume antidepressants and tranquilizers.
According to the official data of the Agency for Medical Devices andMedicinal Products of BiH ALMBiH from November 2022, and for records from 2021, the value of imported and produced antidepressants and tranquilizers was about 22.6 million BAM.
According to the clarifications from the ALMBiH, antidepressants N 06 A are drugs effective in the treatment of moderate and severe depression, organic depressive disorder, and dysthymia chronic moderate depression Anxiolytics are drugs whose basic application is related to the therapy of anxiety states in the framework of various psychiatric disorders. The largest group of anxiolytics consists of benzodiazepines, which have sedative, hypnotic, anticonvulsant, and muscle relaxant effects, in addition to anxiolytic properties.
The largest financial share was held by the group of antidepressants in 2021, from the group of escitalopram, sertraline, and paroxetine. From the group of anxiolytics, bromazepam had the largest turnover, and from the group of hypnotics and sedatives, zolpidem. The ALMBiH stated that all of these drugs have a prescription regime.
Antidepressants are the third place among drugs used in Republika Srpska RS.
In the year 2022, 148.525 prescriptions for sedatives were written, while the price is 2.004 In the last year, 144.222 prescriptions were written about antidepressants, while the cost of the Fund for antidepressants is about 815.000 BAM.
In the total consumption of prescription drugs, they are in third place drugs that affect the nervous system, including antidepressants and tranquilizers.
The Health Insurance Fund of the RS reports that the most commonly prescribed tranquilizer is alprazolam and the antidepressant sertraline Klix.ba.